Renal denervation in heart failure with normal left ventricular ejection fraction. Rationale and design of the DIASTOLE (DenervatIon of the renAl Sympathetic nerves in hearT failure with nOrmal Lv Ejection fraction) trial-Reference-Cited by-同舟云学术

Renal denervation in heart failure with normal left ventricular ejection fraction. Rationale and design of the DIASTOLE (DenervatIon of the renAl Sympathetic nerves in hearT failure with nOrmal Lv Ejection fraction) trial

Published:2013-12 Issue:12 Volume:15 Page:1429-1437
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Verloop Willemien L.¹,Beeftink Martine M.A.¹,Nap Alex²,Bots Michiel L.³,Velthuis Birgitta K.⁴,Appelman Yolande E.²,Cramer Maarten-Jan¹,Agema Willem R.P.⁵,Scholtens Asbjorn M.⁶,Doevendans Pieter A.¹,Allaart Cor P.²,Voskuil Michiel¹

Affiliation:

1. Department of Cardiology; University Medical Centre Utrecht; The Netherlands

2. Department of Cardiology; VU Medical Centre Amsterdam; The Netherlands

3. Julius Centre for Health Sciences and Primary Care; University Medical Centre Utrecht; The Netherlands

4. Department of Radiology; University Medical Centre Utrecht; The Netherlands

5. Department of Cardiology; Diakonessenhuis Utrecht; The Netherlands

6. Department of Nuclear Medicine; University Medical Centre Utrecht; The Netherlands

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hft119/fullpdf

Reference50 articles.

1. Clinical epidemiology of heart failure;Mosterd;Heart,2007

2. Rationale and design of the ‘aldosterone receptor blockade in diastolic heart failure’ trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF);Edelmann;Eur J Heart Fail,2010

3. Outcome of heart failure with preserved ejection fraction in a population-based study;Bhatia;N Engl J Med,2006

4. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function;Zile;Circulation,2002

5. Developed in collaboration with the Heart Failure Association (HFA) of the ESC;McMurray;Eur J Heart Fail,2012

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuromodulation Therapies in Heart Failure: A State-of-the-Art Review;Journal of the Society for Cardiovascular Angiography & Interventions;2023-11

2. Autonomic nervous system and cardiac neuro-signaling pathway modulation in cardiovascular disorders and Alzheimer’s disease;Frontiers in Physiology;2023-01-30

3. Novel treatments for diastolic heart failure;Emerging Technologies for Heart Diseases;2020

4. Renal Sympathetic Denervation Improves Outcomes in a Canine Myocardial Infarction Model;Medical Science Monitor;2019-05-25

5. Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Be;ESC Heart Failure;2018-06-22